1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Hemolysis in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (36.36) | 18.7374 |
| 1990's | 5 (45.45) | 18.2507 |
| 2000's | 2 (18.18) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huseyinov, A; Ozutemiz, O; Saruc, M; Turkel, N; Tuzcuoglu, I; Yuce, G; Yuceyar, H | 1 |
| Bult, H; Coene, MC; Herman, AG; Rampart, M | 1 |
| Banfi, P; Borras, L; Carganico, G; Fos, E; Gambetta, RA; Lobato, C; Mauleón, D; Suesa, N; Zunino, F | 1 |
| Belogi, L; Cavallo, G; Cifone, MG; Croce, C; Guida, G; Mainiero, F; Santiangeli, C; Santoni, A; Tubaro, E | 1 |
| Bazer, F; Chami, O; Megevand, A; O'Neill, C; Ott, T | 1 |
| Backlund, A; Bohlin, L; Claeson, P; Göransson, U; Johansson, S; Luijendijk, T | 1 |
| Akagi, M; Aoki, I; Izushi, K; Mio, M; Tasaka, K | 1 |
| Imura, Y; Kawamura, M; Nishikawa, K; Takatani, M; Terashita, Z; Tsushima, S | 1 |
| Arnout, J; De Lepeleire, I; De Schepper, P; Holmes, I; Miyamoto, Y; van Hecken, A; Vermylen, J | 1 |
| Kertscher, HP; Ostermann, G | 1 |
| Gawrisch, K; Kertscher, HP; Lang, A; Ostermann, G; Weissflog, W | 1 |
1 trial(s) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hemolysis
| Article | Year |
|---|---|
Effectiveness and tolerability of CV-3988, a selective PAF antagonist, after intravenous administration to man.
Topics: Adult; Clinical Trials as Topic; Double-Blind Method; Hemoglobins; Hemolysis; Humans; Injections, Intravenous; Male; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Random Allocation | 1988 |
10 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Hemolysis
| Article | Year |
|---|---|
An experimental model of hemolysis-induced acute pancreatitis.
Topics: Acute Disease; Amylases; Anemia, Hemolytic; Animals; Disease Models, Animal; Hemolysis; Lipase; Pancreatitis; Platelet Activating Factor; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2003 |
Complement derived factors and prostacyclin formation by rabbit isolated peritoneum and cultured mesothelial cells.
Topics: Animals; Blood; Cells, Cultured; Complement Activation; Complement C3; Complement C5; Epithelial Cells; Epithelium; Epoprostenol; Hemolysis; Humans; Peritoneum; Platelet Activating Factor; Rabbits | 1984 |
Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
Topics: Animals; Cell Division; Cell Survival; Chemical Phenomena; Chemistry, Physical; Growth Inhibitors; Hemolysis; Humans; In Vitro Techniques; Lysophospholipids; Platelet Activating Factor; Rabbits; Structure-Activity Relationship; Tumor Cells, Cultured | 1995 |
In vitro and in vivo impact of a new glycosphingolipid on neutrophils.
Topics: Animals; Bone Marrow; Bone Marrow Cells; Calcimycin; Cell Adhesion; Chemotaxis, Leukocyte; Eicosanoids; Erythrocytes; Gangliosides; Hemolysis; Humans; In Vitro Techniques; Inflammation; Leukocyte Count; Mice; Neutrophils; Phagocytosis; Platelet Activating Factor; Platelet Aggregation Inhibitors; Superoxides | 1994 |
Platelet-activating factor may act as an endogenous pulse generator for sheep of luteolytic PGF2alpha release.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Animals; Dinoprost; Endometrium; Estradiol; Estrus; Female; Hemolysis; Interferon-gamma; Organ Culture Techniques; Ovariectomy; Phospholipases A; Platelet Activating Factor; Pregnancy; Progesterone; Recombinant Proteins; Sheep; Uterus | 1999 |
A neutrophil multitarget functional bioassay to detect anti-inflammatory natural products.
Topics: alpha-Amylases; Anti-Inflammatory Agents; Benzoylarginine Nitroanilide; Biological Assay; Biological Products; Cytochalasin B; Digitalis; Digitonin; Digitoxin; Dose-Response Relationship, Immunologic; Hemolysis; Humans; Lamiaceae; Leukocyte Elastase; Magnoliopsida; N-Formylmethionine Leucyl-Phenylalanine; Neutrophil Activation; Neutrophils; Peptides; Plant Proteins; Plants, Medicinal; Platelet Activating Factor; Superoxides; Sweden; Tabernaemontana; Trypsin Inhibitors; Violaceae | 2002 |
Anti-platelet activating factor, anti-leukotriene D4 and some other antiallergic activities of mequitazine.
Topics: 1,2-Dipalmitoylphosphatidylcholine; Animals; Calcium; Cyclic AMP; Guinea Pigs; Hemolysis; Histamine Release; Hypersensitivity; In Vitro Techniques; Lung; Male; Mast Cells; Muscle, Smooth; Phenothiazines; Platelet Activating Factor; Rats; Rats, Inbred Strains; SRS-A; Trachea | 1990 |
Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents.
Topics: Anaphylaxis; Animals; Azepines; Furans; Hemolysis; Humans; Hypotension; Isoquinolines; Male; Microsomes; Phospholipid Ethers; Platelet Activating Factor; Platelet Aggregation; Platelet Aggregation Inhibitors; Pyridinium Compounds; Rabbits; Rats; Rats, Inbred Strains; Shock, Septic; Tetrahydroisoquinolines; Triazoles | 1992 |
[Synthesis and biological activity of isomeric structural analogs of platelet activating factor].
Topics: Chemical Phenomena; Chemistry; Hemolysis; Humans; In Vitro Techniques; Isomerism; Platelet Activating Factor; Platelet Aggregation | 1985 |
[Synthesis and biologic activity of some stable structure analogs of platelet activating factor].
Topics: Chemical Phenomena; Chemistry; Chromatography, Thin Layer; Hemolysis; Humans; In Vitro Techniques; Platelet Activating Factor; Platelet Aggregation | 1985 |